(Q35001014)

5 August 2017

1 reference

title

Developing strategies for liver fibrosis treatment (English)

1 reference

5 August 2017

Frank Murphy

1

1 reference

5 August 2017

Michael Arthur

series ordinal

2

1 reference

5 August 2017

John Iredale

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Expert Opinion on Investigational Drugs

5 August 2017

1 reference

5 August 2017

11

1 reference

5 August 2017

11

1 reference

5 August 2017

1575-1585

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

5 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Lamivudine for hepatitis B in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Colchicine in the treatment of cirrhosis of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Leukocytes as modulators of stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Induction of cellular processes containing collagenase and retinoid by integrin-binding to interstitial collagen in hepatic stellate cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

The 5' stem-loop regulates expression of collagen alpha1(I) mRNA in mouse fibroblasts cultured in a three-dimensional matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

Protease inhibitors suppress TGF-β generation by hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1575

10.1517/13543784.11.11.1575

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference